2025 United States Clinical Diagnostics Market Revenue Opportunities Report
Description
The 2025 United States Clinical Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Clinical Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Clinical Diagnostics Market in the United States are Abbott Laboratories, Quest Diagnostics, Laboratory Corporation of America (LabCorp), and Bio-Rad Laboratories. Abbott is a global leader specializing in molecular diagnostics, point-of-care testing, and digital health, offering real-time data solutions to enhance patient care. Quest Diagnostics, with a nationwide network, provides extensive clinical testing services including molecular diagnostics, genetic screening, and infectious disease testing, processing a vast volume of tests daily. LabCorp is similarly prominent, offering comprehensive pathology, genomic testing, and personalized medicine services, and has recently expanded through acquisitions to strengthen its clinical diagnostic capabilities. Bio-Rad Laboratories focuses on advanced biotechnology solutions, such as multiplex immunoassay platforms, enabling faster disease detection and improved clinical decision-making.
These companies lead the market by leveraging innovations in molecular diagnostics, automation, and digital integration. Abbott and Bio-Rad emphasize advanced molecular and immunodiagnostics technologies, while Quest and LabCorp provide broad clinical services with significant contributions to precision medicine and clinical trials support. Their combined efforts reflect a strong focus on improving diagnostic accuracy, accelerating test processing times, and supporting personalized treatment strategies amid rising demand for advanced clinical diagnostics in the U.S.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Clinical Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Clinical Diagnostics Market in the United States are Abbott Laboratories, Quest Diagnostics, Laboratory Corporation of America (LabCorp), and Bio-Rad Laboratories. Abbott is a global leader specializing in molecular diagnostics, point-of-care testing, and digital health, offering real-time data solutions to enhance patient care. Quest Diagnostics, with a nationwide network, provides extensive clinical testing services including molecular diagnostics, genetic screening, and infectious disease testing, processing a vast volume of tests daily. LabCorp is similarly prominent, offering comprehensive pathology, genomic testing, and personalized medicine services, and has recently expanded through acquisitions to strengthen its clinical diagnostic capabilities. Bio-Rad Laboratories focuses on advanced biotechnology solutions, such as multiplex immunoassay platforms, enabling faster disease detection and improved clinical decision-making.
These companies lead the market by leveraging innovations in molecular diagnostics, automation, and digital integration. Abbott and Bio-Rad emphasize advanced molecular and immunodiagnostics technologies, while Quest and LabCorp provide broad clinical services with significant contributions to precision medicine and clinical trials support. Their combined efforts reflect a strong focus on improving diagnostic accuracy, accelerating test processing times, and supporting personalized treatment strategies amid rising demand for advanced clinical diagnostics in the U.S.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
